Fediuk, D. J., Nucci, G., Dawra, V. K., Cutler, D. L., Amin, N. B., Terra, S. G., . . . Sahasrabudhe, V. (2020). Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor. Clin Pharmacokinet.
Citação norma ChicagoFediuk, Daryl J., Gianluca Nucci, Vikas Kumar Dawra, David L. Cutler, Neeta B. Amin, Steven G. Terra, Rebecca A. Boyd, Rajesh Krishna, and Vaishali Sahasrabudhe. "Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor." Clin Pharmacokinet 2020.
MLA citiranjeFediuk, Daryl J., et al. "Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor." Clin Pharmacokinet 2020.